[28]

2013-2014

Trinidad

Prospective,

observational

Hospital

To obtain overview on MRSA and MSSA clinical isolates and characterize them by microarray hybridization and by multi locus sequence typing (MLST)

[29]

2016

Northern region of Trinidad and Tobago

Retrospective,

observational

Rural Community

To delineate the SCCmec type and toxin genes, and genes mediating antibiotic resistance in MRSA isolates

[30]

2011

Cuba

Retrospective,

observational (Epidemiological analysis)

Hospital

To characterize MRSA isolates recovered from Cuban hospitals by a variety of methods

[31]

2012

Haiti

Cross-sectional analysis

Community

To describe the molecular epidemiology of nasal carriage isolates of S. aureus.

[32]

2017-2018

St. Kitts

Prospective,

observational

Hospital

To determine the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the frequency and population structure of MRSA in St. Kitts and Nevis

[33]

2013

Trinidad and Tobago

Prospective,

observational

Hospital

To assess the prevalence of MRSA in patients hospitalized in the surgical wards of, and determine associated risk factors

[34]

2008

Jamaica

Prospective,

observational

Hospital

To determine the prevalence of MRSA and characterize the isolates at the University Hospital of the West Indies (UHWI)

[35]

1997-1998

Trinidad

Prospective,

observational

Hospital

Community

To determine the prevalence of MRSA isolated from hospital and community practices and their anti-microbial resistance profiles

[36]

2005-2006

Trinidad

Prospective,

observational

Hospital

To investigate the prevalence of mupirocin resistance among clinical isolates of MRSA at SFGH

[37]

2000-2001

Trinidad and Tobago

Retrospective

Hospital

To delineate and document

the clonal relatedness of all MRSA clinical isolates

[38]

2013

Guyana

Prospective

Hospital

To determine the prevalence and molecular characteristics of MRSA isolates